Results 111 to 120 of about 2,926 (159)

[Sinonasal ameloblastoma: Clinical case presentation and literature review]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Martínez-Fernández FJ   +1 more
europepmc   +1 more source

Linfoma no Hodgkin Anaplásico de células grandes ALK

open access: yes
El linfoma anaplásico de células grandes (LACG) es una forma poco común de linfoma no Hodgkin. Es un tipo grave de cáncer que afecta a las células llamadas linfocitos T. Algunas formas de LACG se consideran agresivas y se propagan rápidamente.
Ortega-Espinoza , Melissa   +2 more
core   +1 more source

Ileocolic Intussusception Secondary to B-Cell Lymphoma: A Case Report. [PDF]

open access: yesGE Port J Gastroenterol
Guimarães A   +4 more
europepmc   +1 more source

Leucemia agresiva de células natural killer: importancia de la inmunofenotipificación

open access: yes
Aggressive natural killer cell leukaemia (ANKL) is a rare neoplasm of NK cells with poor prognosis, varied morphology and positivity for CD2, CD3 epsilon and CD56, negative for surface CD3 and CD5.
Arya, S   +4 more
core  

[Cutaneous-pericardial fistula and purulent pericarditis secondary to a complicated pericardiocentesis: Case report]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Islas-Muñoz BD   +5 more
europepmc   +1 more source

Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome [PDF]

open access: yesBiomedica
Medina D   +8 more
europepmc   +1 more source

Herpes simplex virus esophagitis in an immunocompromised patient: case report of an atypical presentation. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Layza-Reyes GD   +5 more
europepmc   +1 more source

Regenerative therapies for complex diabetic foot wounds: a therapeutic challenge. [PDF]

open access: yesJ Vasc Bras
Grillo VTRDS   +7 more
europepmc   +1 more source

MicroRNAs and vascular damage in chronic kidney disease: advances and clinical implications. [PDF]

open access: yesJ Bras Nefrol
Cunha RSD   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy